Janux Therapeutics, Inc. (JANX) Insider Trading

Name: Janux Therapeutics, Inc. (JANX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 1, 2026): David Alan Campbell (President and CEO): Gift of 123,840 shares.

Get alerted when insiders trade JANX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta